Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CV Exam III > Anti anginal Agents > Flashcards

Anti anginal Agents Flashcards

1
Q

β-Adrenergic Antagonists (β-Blockers)

Drug list

A
  • Atenolol
  • Metoprolol
  • Propranolol
  • Timolol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Organic Nitrates

Drug list

A
  • Nitroglycerin
  • Isosorbide dinitrate
  • Isosorbide mononitrate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Calcium Channel Blockers (CCBs

Drug list

A
  • Dihydropyridines(DHPs)
    • Amlodipine
    • Felodipine
    • Nicardipine
    • Many others…
  • Non-dihydropyridines
    • Diltiazem
    • Verapamil
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Angina Pectoris

A
  • The primary symptom of ischemic heart disease
  • Coronary artery disease is usually the underlying cause

chest pain from ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Types of Angina

A
  • Effort angina (aka classic angina)
  • Variant angina (aka vasospastic or Prinzmetal’sangina)
  • Unstable angina (aka acute coronary syndrome)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

•Effort angina (aka classic angina)

A
  • Myocardial O2requirement increases during exercise, but coronary blood flow does not increase proportionately
  • Resulting ischemia usually, but not always, leads to pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

•Variant angina (aka vasospastic or Prinzmetal’sangina)

A

•O2delivery decreases as a result of reversible coronary vasospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

•Unstable angina (aka acute coronary syndrome)

A

•Angina at rest or an increase in the severity, frequency, and duration of chest pain in patients with previously stable angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Molecular Mechanisms of Anti-AnginalAgents in the Vasculature
•Increase cGMP

A
  • Nitroglycerin (NTG), other nitrates and nitrites

* Potentiated by PDE inhibitors (ed drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Molecular Mechanisms of Anti-AnginalAgents in the Vasculature

•Decrease intracellular Ca2+

A

•Calcium channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Molecular Mechanisms of Anti-AnginalAgents in the Heart

A
  • Decrease intracellular Ca2+
    • Calcium channel blockers (reduces heart rate)
      * Verapamil > diltiazem > DHPs
    • Beta blockers (reduces contractility and heart rate)

•Physiologic effect: decrease rate and contractility in cardiac myocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Organic Nitrates

Prototype

A

nitroglycerin (NTG)

  • Available in many different formulations:
    • Sublingual tablet or spray
    • Sustained release oral capsules
    • Buccal tablets or gel
    • Ointment
    • Transdermal patch
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Organic Nitrates

Other Agents

A
  • Isosorbide dinitrate
  • Isosorbide mononitrate
  • Sublingual, oral, or sustained release tablets

they are extended release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Organic Nitrates: Pharmacodynamics

A
  • MOA: metabolism releases NO
  • Dilates both arterial and venous vessels—decreases TPR and venous return
  • Decreases both preload & afterload
  • Mainly relaxation of large veins decreases venous return decreases preload decreases O2demand (major effect), smaller in afterload
  • Primary antiischemic effect is to decrease myocardial O2demand by producing systemic vasodilation (more so than coronary vasodilation)
  • Prevents coronary vasospasm (dialate coronaries)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nitrate Use in Angina

A
  • First-line therapy for an acute anginalattack (typically sublingual administration, spray equally effective)
  • Long-acting oral and transdermal formulations improve exercise tolerance and time to onset of angina
  • Improve antianginal and antiischemiceffects of beta blockers and calcium channels blockers
  • Long-term utility is limited by tolerance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Nitrate Tolerance

A
  • Effectiveness diminishes significantly with continuous use
  • Multiple mechanisms proposed
  • Generally not a problem with sublingual nitroglycerin (drug is only in body for short time)
  • Limits the usefulness of oral and transdermal nitroglycerin and oral isosorbide mono-and dinitrate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Prevention of Nitrate Tolerance

A
  • Intermittent therapy with a nitrate-free interval of at least 8 hours may prevent tolerance (for q 24 hour period)
  • Angina frequency and silent ischemia may increase during off-patch hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Nitrates: Adverse Effects

A

•Common: orthostatic hypotension, syncope, throbbing headache, flushing

  • Drug-drug interaction: synergistic hypotension with phosphodiesterase type 5 (PDE5) inhibitors (e.g., sildenafil, tadalafil, vardenafil) (bc both increase cgmp)
    • Can lead to myocardial infarction and death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

β-Adrenoreceptor Antagonists

Non-selective

Non-ISA

A

Propranol
carvedilol (also blocks a1 and has vasodilating activity)
nadolol
timolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

β-Adrenoreceptor Antagonists

Non-selective

ISa

A

labetalol (also blocks a1 and has vasodilating activity)
carteolol
penbutolol
pindolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

β-Adrenoreceptor Antagonists

B1 selective (Cardioselective)

Non-isa

A 
metoprolol
atenolol
esmolol
bisoprolol
betaxolol
22
Q

β-Adrenoreceptor Antagonists

B1 selective (Cardioselective)

ISA

A

acebutolol

nebivolol (b3 agonist and has vasodilating activity)

23
Q

Beta Blockers: Pharmacodynamics

A
  • Reduce cardiac work (i.e., O2consumption) by decreasing heart rate and contractility
  • Most are not vasodilators; no effect on O2supply
24
Q

Beta Blocker Use in Angina

A
  • Prototype: propranolol
  • First-line therapy to reduce frequency of angina (i.e., prophylaxis) and improve exercise tolerance (for effort angina)
  • Reduce O2requirement by reducing heart rate and contractility
  • All types are equally effective in exertional angina; cardioselective(β1-selective) often preferred
  • NOT effective in variant angina (caused by vasospasm, beta blocker with keep arteries from vasodilating so you exacerbate the problem)
25
Q

Beta Blockers Stabilize Heart Rate

A

antagonists dampen physiologic agonists so their efficacy depends on how much agnoist is available, so beta blockers shine when you ahve more norepi in system,

they lower and stabilize heart rate so it responds better

26
Q

Beta Blockers Prolong Survival After MI

A
  • Timolol, propranolol, and metoprolol have been specifically studied in large-scale clinical trials
  • Use of other beta-blockers for this indication is less compelling

prevents irreversible damage

hesitant to use atenolol

propranolol can get to brain and causebc it is lipid soluble

depression sexual dysfunction

27
Q

Beta Blockers & Systolic Heart Failure

A

additive benefit with ACEI and beta blockers in HF

28
Q

Beta Blockers: Adverse Effects

A

•Most common: bradycardia and fatigue

  • Relative contraindications
    • Asthma/COPD (slective may be ok)
    • Diabetes
    • Variant angina
    • Acute decompensated heart failure

•Can cause heart block, especially if combined with other negative inotropes (e.g., verapamil, diltiazem)

29
Q

Beta Blocker

No Antagonist

A

full stimulation

30
Q

Beta Blocker

without agonism

A

no stimulation without some sympatholytic ativity

31
Q

Beta Blocker

with partial agonism

A

doesnt matter bc cell still gets some stimulation

32
Q

Beta Blocker Withdrawal

A

hyperstimulation

33
Q

Calcium Channel Blockers (CCBs)

A

All CCBs bind to L-type Ca++channels. But the two classes bind to different sites, resulting in different effects on vascular versus cardiac tissue. voltage gated

34
Q

Non-dihydropyridines

A
  • Prominent cardiac effects, but also act at vascular tissues
  • Verapamil >Diltiazem
35
Q

Dihydropyridines(DHPs)

A
  • Predominantly arteriolar vasodilation effects

* Amlodipine, Clevidipine, Felodipine, Isradipine, Nicardipine,

36
Q

Pharmacokinetic Properties of CCBs

A
  • Good oral absorption but high 1stpass effect
  • Amlodipine, felodipine, isradipineslowly absorbed, long t1/2is advantage (used as antianginals (first two))
  • DHPs with long plasma half-lives preferred to minimize reflex cardiac effects; extended release preparations available (short acting could make worse)
37
Q

Nifedipine, clevidipine, verapamil, and diltiazemsometimes used

A

IV

38
Q

CCBs: Pharmacodynamics

A
  • Relaxation of vascular smooth muscle causes peripheral vasodilation
  • Arterioles are more sensitive than veins
  • Reduce afterload and decrease O2demand
  • Little effect on preload
  • Also increase O2supply due to dilation of coronaries

reduce demand and increase supply

39
Q

Calcium Channel Blocker Use in Angina

A
  • Preferred agents: diltiazem, verapamil, amlodopine, or felodipine
  • Added to or substituted for beta blockers in chronic stable angina
  • Also effective in vasospastic angina
  • Reduce O2requirement by reducing heart rate and contractility
  • Increase O2delivery by vasodilation and reversal of vasospasm

no mortality reduction

40
Q

Cardiovascular Effects of CCBs

Dihydropyridines

A

Vasodilation
(CoronaryFlow) - 5

Supressionof Cardiac Contractility -1

Supressionof Automaticity
(SA Node)-1

Supressionof Conduction
(AV Node)-0

41
Q

Cardiovascular Effects of CCBs

non-Dihydropyridines

A

Vasodilation
(CoronaryFlow) - 3

Supressionof Cardiac Contractility - 2

Supressionof Automaticity
(SA Node) - 5

Supressionof Conduction
(AV Node) - 4

42
Q

CCBs: Adverse Effects & Toxicity

A
  • Generally very well tolerated
  • Excessive vasodilation –dizziness, hypotension, headache, flushing, nausea; diminished by long-acting formulations and long half-life agents
  • Constipation (esp., verapamil), peripheral edema, coughing, wheezing, pulmonary edema
43
Q

Use of verapamil/diltiazemwith a b-blocker is

A

contraindicatedbecause of the potential for AV block

44
Q

Verapamil/diltiazem should not be used in patients with

A

ventricular dysfunction, SA or AV nodal conduction defects and systolic BP

45
Q

Short-acting dihydropyridinescan cause

A

reflex tachy

46
Q

Are Calcium Channel Blockers Safe?

Short-acting Nifedipine

A

Proischemiceffect
+/-

Negative inotropic effect
+

Effects on rhythm
?

Marked hypotension
+

Reflex increase in sympathetic activity
+

Prohemorrhagiceffects
?

47
Q

Are Calcium Channel Blockers Safe?

Long-acting CCBs

A

Proischemiceffect

-
Negative inotropic effect

+/-
Effects on rhythm

-
Marked hypotension

-
Reflex increase in sympathetic activity

-
Prohemorrhagiceffects
-

48
Q

give long acting ccb for

A

angina

49
Q

Ranolazine

A
  • Relatively newer antianginal drug
  • MOA: late sodium channel blocker
  • Typically reserved for angina that is refractory to treatment with beta blockers, calcium channel blockers, and nitrates
  • Used either in combination with beta blocker or as a substitute in patients who cannot receive beta blockers
50
Q

Preventative Therapies

A
  • Regular aerobic exercise
  • Stress reduction
  • Smoking cessation
  • Weight control
  • Blood pressure control
  • Diabetes management
  • Pharmacotherapies to prevent cardiovascular events
51
Q

Angina Pharmacotherapies to prevent cardiovascular events

A
  • Aspirin (or clopidogrel) (antiplatelet)
  • HMG-CoA reductase inhibitors (the –statins)
  • ACE inhibitors (the –prils) and ARBs (the –sartans) (prevent detrimental remodeling)
52
Q

Clinical Pharmacology of Angina

A
  • Three primary drug classes are utilized: beta blockers, calcium channel blockers, & nitrates
  • Nitrates are the mainstay of treatment for acutesymptoms
  • Cardioselectivebeta blockers are often recommended as initial first-line therapy for long-term prophylaxis
  • Combinations may be more effective than monotherapy
  • CCBs or nitrates relieve vasospastic angina by preventing coronary artery spasm

CV Exam III (17 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions